TrialScope Chosen by H. Lundbeck A/S to Provide Clinical Trial Disclosure Services

Share Article

TrialScope, the global leader in clinical trial disclosure and transparency technology, has been selected by H. Lundbeck A/S as its partner for maintaining disclosure compliance.

TrialScope’s Disclosure Services Team to Help Ensure Regulatory Compliance, Support Lundbeck’s Commitment to Trial Transparency

TrialScope, the global leader in clinical trial disclosure and transparency technology, has been selected by H. Lundbeck A/S as its partner for maintaining disclosure compliance. Lundbeck is a global pharmaceutical company focusing on brain health. Lundbeck will have access to TrialScope’s full range of disclosure services, including protocol registration, study results disclosure, redaction and plain-language summaries (PLS), managed with the TrialScope Disclose™ platform to provide consistency and efficiency across disclosure activities.

“At TrialScope, we are proud to be market leaders delivering the most trusted and comprehensive clinical trial disclosure solution,” said TrialScope CEO Jeff Kozloff. “In addition to our transparency cloud technology, our expert-level disclosure services lessen the compliance burden for sponsors. We are extremely excited to add Lundbeck to the TrialScope disclosure community, and we look forward to an ongoing, successful partnership.”

“We chose TrialScope because of its deep expertise in clinical trial disclosure,” said Kerstin Dahlström, Lundbeck Director Transparency & Outsourcing. “The regulatory requirements for disclosure compliance are numerous and complex. We wanted a partner with a proven track record, a partner that we could rely on, one that we could work with as a de facto extension of our internal disclosure team.”

About TrialScope

TrialScope makes centralizing, structuring and activating clinical trial information simple, for use across the organization and at every stage of the study. Our integrated platform is used by 16 of the top 20 clinical trial sponsors in the world, who rely on TrialScope to ensure disclosure compliance, maximize trial transparency, improve patient engagement and accelerate study recruitment. To learn more, visit TrialScope.com.

TrialScope recently was acquired by Informa Pharma Intelligence, combining its powerful technology for disclosure, transparency and recruitment with leading brands, data and solutions for the clinical trials and broader pharmaceutical and biomedical industry.

About Informa Pharma Intelligence

Informa Pharma Intelligence powers a full suite of analysis products—Datamonitor Healthcare™, Sitetrove™, Trialtrove™, Pharmaprojects™, Medtrack™, Biomedtracker™, Scrip™, Pink Sheet™ In Vivo™ and most recently TrialScope—to deliver the data needed by the pharmaceutical and biomedical industry to make decisions and create real-world opportunities for growth.

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Darcy Grabenstein
TrialScope
+1 929-278-5784
Email >
Visit website